| pioglitazone / Generic mfg. |
NCT00013598: Treatment of Nonalcoholic Steatohepatitis With Pioglitazone |
|
|
| Completed | 2 | 30 | US | Pioglitazone | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Fatty Liver, Nonalcoholic Steatohepatitis | | 03/04 | | |
NCT00062764: Treating Nonalcoholic Steatohepatitis With Pioglitazone |
|
|
| Completed | 2 | 18 | US | Actos (Pioglitazone) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Hepatitis | 02/09 | 02/09 | | |
NCT01703260: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis |
|
|
| Terminated | 2 | 20 | US | Roflumilast, Daxas, Daliresp, Pioglitazone, Actos, Placebo | AstraZeneca | Nonalcoholic Steatohapatitis | 09/14 | 09/14 | | |
NCT01068444: The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis |
|
|
| Completed | 2 | 90 | RoW | Pioglitazone, GLITOS, placebo | Kaohsiung Medical University Chung-Ho Memorial Hospital | Hepatitis | 07/20 | 07/20 | | |
NCT05254626: Efficacy and Safety of Dapagliflozin in Patients With Non-alcoholic Steatohepatitis |
|
|
| Active, not recruiting | 2 | 100 | RoW | Dapagliflozin 10Mg Tab, Pioglitazone 30 mg | Cairo University | Non-alcoholic Steatohepatitis | 01/24 | 09/24 | | |
NCT04501406: Low-Dose Pioglitazone in Patients With NASH (AIM 2) |
|
|
| Recruiting | 2 | 166 | US | Pioglitazone, Actos, Placebo | University of Florida, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 2 Diabetes Mellitus (T2DM), Nonalcoholic Steatohepatitis | 08/27 | 08/27 | | |
